The core competitiveness is medical big data, and data will become core resources and barriers. Through pharmaceutical big data, we can better understand the market and better serve users. Qiu Zhongxun pointed out that with the gradual migration of pharmaceutical market share to the retail side, pharmaceutical production and R&D companies have also seen the value and potential of data for sales, and Yaodou.net has also launched technical solutions to serve various upstream demands in a timely manner.